MANAGEMENT OF MYELODYSPLASTIC SYNDROMES WITH ERYTHROPOIESIS STIMULATING AGENTS (ESAS): A REAL-LIFE EXPERIENCE

被引：0
|
作者：
Cerchione, C. [1 ]
Vitagliano, O. [1 ]
Pareto, A. E. [1 ]
Di Perna, M. [1 ]
Cerciello, G. [1 ]
Soriente, I. [2 ]
Alfinito, F. [1 ]
Pane, F. [1 ]
机构：
[1] Hematol Ematol & Trapianto Federico II, Naples, Italy
[2] Osped Umberto I, Hematol, Nocera Inferiore, SA, Italy
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB2114
引用
收藏
页码：840 / 840
页数：1
相关论文
共 50 条
  • [41] Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents: an observational cohort study
    Garelius, Hege Kristin Gravdahl
    Bagguley, Timothy
    Taylor, Adele
    Fenaux, Pierre
    Bowen, David
    Symeonidis, Argiris
    Mittelmann, Moshe
    Stauder, Reinhard
    Cermak, Jaroslav
    Sanz, Guillermo
    Langemeijer, Saskia
    Malcovati, Luca
    Germing, Ulrich
    Sanhes, Laurence
    d'Aveni, Maud
    Culligan, Dominic
    Kotsianidis, Ioannis
    Koinig, Karin A.
    van Marrewijk, Corine
    Crouch, Simon
    Dewitte, Theo
    Smith, Alexandra
    Hellstroem-Lindberg, Eva
    LANCET HAEMATOLOGY, 2025, 12 (02): : e128 - e137
  • [42] Real-Life Cost Analysis of Anemia Treatment with Erythropoiesis Stimulating Agents In Cancer Patients Receiving Chemotherapy.
    Duran, Aurea
    Spaepen, Erik
    Lamotte, Mark
    Walter, Evelyn
    Kutikova, Lucie
    Pujol, Beatriz
    Annemans, Lieven
    BLOOD, 2010, 116 (21) : 1559 - 1560
  • [43] Lenalidomide (LEN) In Lower-Risk Myelodysplastic Syndromes (MDS) with Karyotypes Other Than Deletion 5q and Refractory to Erythropoiesis-Stimulating Agents (ESAs).
    Sibon, David
    Cannas, Giovanna
    Barraco, Fiorenza
    Prebet, Thomas
    Vey, Norbert
    Banos, Anne
    Besson, Caroline
    Corm, Selim
    Blanc, Michel
    Slama, Borhane
    Perrier, Herve
    Fenaux, Pierre
    Wattel, Eric
    BLOOD, 2010, 116 (21) : 1632 - 1632
  • [44] Lenalidomide in Myelodysplastic Syndromes: An Erythropoiesis-Stimulating Agent or More?
    Komrokji, Rami S.
    Lancet, Jeffrey E.
    List, Alan F.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2010, 5 (01) : 9 - 14
  • [45] Lenalidomide in Myelodysplastic Syndromes: An Erythropoiesis-Stimulating Agent or More?
    Rami S. Komrokji
    Jeffrey E. Lancet
    Alan F. List
    Current Hematologic Malignancy Reports, 2010, 5 : 9 - 14
  • [46] ANALYSIS OF RESPONSE TO ERYTHROPOIETIN-STIMULATING AGENTS (ESAs) IN PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS), EXPERIENCE OF A CENTER
    Jimenez, M.
    Molero, A.
    Saumell, S.
    Montoro, J.
    Merchan, B.
    Raheja, P.
    Varela, A.
    Perez, A.
    Gallur, L.
    Tazon, B.
    Ortega, M.
    Rodriguez, S.
    Bosch, F.
    Valcarcel, D.
    HAEMATOLOGICA, 2018, 103 : 183 - 183
  • [47] A REAL-LIFE STUDYOF DEFERASIROX IN PATIENTS WITH HIGHER RISK MYELODYSPLASTIC SYNDROMES
    Musto, P.
    Maurillo, L.
    Simeon, V.
    Poloni, A.
    Finelli, C.
    Balleari, E.
    Ricco, A.
    Rivellini, F.
    Cortelezzi, A.
    Tarantini, G.
    Villani, O.
    Breccia, M.
    Niscola, P.
    Sanna, A.
    Clissa, C.
    Voso, M. T.
    Fenu, S.
    Venditti, A.
    Santini, V.
    Angelucci, E.
    LEUKEMIA RESEARCH, 2017, 55 : S163 - S163
  • [48] Thrombopoiesis-stimulating agents and myelodysplastic syndromes
    Brierley, Charlotte K.
    Steensma, David P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (03) : 309 - 323
  • [49] Evaluation for disparities in erythropoiesis-stimulating agents (ESAS) administration in patients with cancer
    Wong, Hui-Lee
    Zhang, Rongmei
    Alexander, Michael
    Feng, Yuhui
    Lo, An-Chi
    Ryan, Qin
    Izem, Rima
    Wernecke, Michael
    Vega, Amarilys
    Kelman, Jeffrey A.
    Graham, David J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 510 - 510
  • [50] Erythropoietic-Stimulating Agents (ESAs) Are Not Associated with a Transient Risk of Deep Vein Thrombosis (DVT) in Myelodysplastic Syndromes (MDS)
    Sato, Masayo
    Smith, Sheila R. Weiss
    Davidoff, Amy
    Baer, Maria R.
    Ke, Xuehua
    Gore, Steven D.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S82 - S82
12345